Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study
Gianluca D’Onofrio(Centre Hospitalier Universitaire Sainte-Justine), Rima Nabbout(Hôpital Necker-Enfants Malades), Claude Cancés(Hôpital des Enfants), Mathieu Kuchenbuch(Hôpital Necker-Enfants Malades), Théo Teng(Hôpital Necker-Enfants Malades), Dorothée Ville(Hospices Civils de Lyon), Nathalie Villeneuve(Henri Gastaut Hospital), Sylvia Napuri(Centre Hospitalier Universitaire de Rennes), Véronique Staath(Hôpital d'Hautepierre), Anne de Saint Martin(Epilepsy Foundation), Mathieu Milh(Inserm), Caroline Hachon‐Le Camus(Hôpital des Enfants), Anne Lépine(Assistance Publique Hôpitaux de Marseille), Nicole Chémaly(Hôpital Necker-Enfants Malades), Jean‐Michel Pédespan(Hôpital Pellegrin), Béatrice Desnous(Inserm)
Cited by 39
Related Papers
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
|Nature Genetics|2010|509
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|151
Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy
|Journal of Clinical Investigation|2019|106
Diagnosis delay in West syndrome: misdiagnosis and consequences
|European Journal of Pediatrics|2012|88